Peer Review History
| Original SubmissionJune 5, 2020 |
|---|
|
Dear Dr Ruby, Thank you for submitting your manuscript entitled "The non-coding small RNA SsrA is secreted by Vibrio fischeri to modulate critical host responses" for consideration as a Research Article by PLOS Biology. Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I'm writing to let you know that we would like to send your submission out for external peer review. However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire. Please re-submit your manuscript within two working days, i.e. by Jun 17 2020 11:59PM. Login to Editorial Manager here: https://www.editorialmanager.com/pbiology During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit. Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review. Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible. Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission. Kind regards, Roli Roberts Roland G Roberts, PhD, Senior Editor PLOS Biology |
| Revision 1 |
|
Dear Dr Ruby, Thank you very much for submitting your manuscript "The non-coding small RNA SsrA is secreted by Vibrio fischeri to modulate critical host responses" for consideration as a Research Article at PLOS Biology and please accept our apologies for the time it has taken us to contact you with a decision on your study. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and three independent reviewers, whose expertise and comments you can find at the end of this email. Reviewer 2, Shelley Payne, has identified herself. As you will see, all of the reviewers are quite supportive of the work, although they do raise several issues that will need to be addressed before we can consider its publication. While many issues can be addressed by additions/modifications to the text and re-analysis of sequencing data, some points would take a more effort to address. Of these, we find the competition assay suggested by the first two reviewers to be the most relevant, which can also address one major point of the 3rd reviewer (a function of ssrA independent of smpB). We would also like to stress the following comment of the 3rd reviewer “The Conclusions section should be changed into a proper discussion, where the authors should more critically reflect upon the strengths and weaknesses of their present model”. This reflects initial thoughts of our Academic Editor when reading the paper and some of the other reviewers points. In all, in light of the reviews, we will be happy to invite a thorough revision of the work that addresses the reviewers' comments, including a competition assay, if feasible. Your revised manuscript is likely to be sent for further evaluation by at least some of the reviewers before we can make a decision on publication. We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology. **IMPORTANT - SUBMITTING YOUR REVISION** Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript: 1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript. *NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point. You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response. 2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type. *Re-submission Checklist* When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record. Please make sure to read the following important policies and guidelines while preparing your revision: *Published Peer Review* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *PLOS Data Policy* Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5 *Blot and Gel Data Policy* We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Roli Roberts Roland G Roberts, PhD, Senior Editor, PLOS Biology ***************************************************** REVIEWS: Reviewer's Responses to Questions Reviewer identities: Reviewer #1: No Reviewer #2: Yes: Shelley M. Payne Reviewer #3: No Reviewer expertise: Reviewer #1: effects of Vibro spp host development and metabolism Reviewer #2: genetics of Vibrio sRNAs and metabolism Reviewer #3: bacterial non-coding RNA; RNA in bacteria-host communications Review Comments to authors: Reviewer #1: In the manuscript entitled "The non-coding small RNA ssrA is secreted by Vibrio fischeri to modulate critical host responses," the authors show convincingly that the small RNA ssrA, a transfer messenger RNA with a well-established role in ribosome rescue, is secreted in membrane vesicles and taken up by squid light organ epithelial cells. This attenuates the host innate immune response, allowing V. fischeri persist in the squid light organ. This is a fascinating and important story that adds to our knowledge of the interaction of host epithelia with commensals. Some observations are underdeveloped but do not detract from the overall impact of the reported findings. The following are specific comments: Major comments: 1) Line 39: Reference 27 to V. cholerae OMV is not appropriate here. This work shows that a sRNA increases V. cholerae OMV production due to a decrease in expression of the outer membrane protein OmpA. OmpA, itself, is a virulence factor. The increase in OmpA expression in a sRNA mutant is most likely responsible for increased pathogen virulence, and no evidence is presented that the sRNA is transferred to the host cytoplasm or that it impacts the host epithelium directly. 2) Line 95: Hemolymph RNAseq: The majority of bacterial RNA's found in host hemolymph were tRNA's and ribosomal RNA's. a) Is this a consequence of the stability of these RNA's? Is there any evidence of RNA fragments or degradation? b) For sRNA's, did the reads include the entire sRNA or were all parts of the sRNA equally represented in the reads? c) Were there any non-V. fischeri bacterial RNA's detected in the hemolymph? In other words, are all these bacterial RNA's coming from the light organ, which is mono-colonized? d) The authors state that the same RNA's were detected in OMV's regardless of what medium V. fisheri was grown in. Is ssrA more abundantly transcribed than the other sRNA's detected in OMV's and hemolymph or is it selectively packaged into OMVs? 3) Line 111: The statement here that the OMV's differ only in the absence of ssrA seems too strong given the evidence provided. For instance, I wonder if the size and number of OMV's is the same and whether this might also affect the phenotype. 4) Line 177: Are there other reasons in vivo light emission could be less in the ssrA mutant? For instance, are the lux genes just has highly expressed? Is high cell density not signaled or sensed in vivo? 5) Figure 3B: In this heat map, it looks like ssrA rescue is very incomplete. In other words, the host response to the rescued ssrA mutant looks more like the response to the mutant itself than that to the wild-type bacterium. Is it possible that overexpression of ssrA results in less packaging into OMV's? 6) Line 281: Is it also possible that OMV's formed outside the squid are different in some way or that OMV's that lack ssrA function in a dominant negative way. Perhaps an in vivo competition experiment would address the question of whether proximity to the epithelium is necessary for rescue by ssrA+ OMV's. 7) Line 313-Hemocyte experiments: It is not clear from this discussion whether the experiments in hemocytes are relevant to what is observed in squid light organ epithelial cells. Shouldn't activation of an innate immune RNA sensor lead to a more robust immune response? I'm not convinced that these experiments strengthen the story. Minor comments: 1) Line 92: "one such study…" This wording is awkward and gives the impression that there were many similarly performed RNAseq studies of squid hemolymph, but only one gave this result. I suspect this is not the case. 2) Line 145: Should this be Figure 1D rather than 1B? 3) Line 150: Should this be Figure 1E rather than 1C? 4) Line 157: This sentence is confusing. Which signals and secreted molecules are the authors referring to? Is ssrA a signal or a bacterial effector? 5) Line 170: I apologize for the nit-picking, but technically the bacterial production of MAMP's has not been measured even qualitatively. I would say, instead, that the host response to these MAMP's is not different in the mutant. 5) Line 301: Is the implication that the juveniles do not take in nutrients other than those in the yolk sac? For the non-experts, it would be helpful to state this directly. 6) Line 305: This sentence is unclear. What happened to a "significantly greater extent as confirmed by electron microscopy"? Reviewer #2: The authors have established the squid Euprymna scolopes and its symbiont Vibrio fischeri as an outstanding model for understanding host-microbe interactions. In particular, they have studied every stage of colonization and persistence from both the host and bacterium perspective. This has allowed a detailed description of the genetics, biochemistry and biology of this complex interaction. In the current manuscript, they show that a small ncRNA produced by the bacteria enters host cells and manipulates the immune response toward the vibrios, thus preserving the mutualistic interaction. Failure to produce and deliver the ncRNA results in altered innate immune signaling and reduced persistence of the bacteria, a response that is detrimental to both host and bacterium. The authors use a variety of techniques to show that the effect of the ncRNA is on the host, not the bacterium, and to establish its localization and effects on host cells. Overall, this study will be of broad interest, and it provides insights into the interaction of the host with a beneficial bacterium, an area that is understudied compared to host-pathogen interactions. Specific questions and comments : 1. SsrA is found in vesicles and there is evidence in previous studies that vesicles can deliver cargo to host cells, but is there direct evidence that SsrA enters the host cell through vesicles? Can the RNA also be secreted into the environment and taken up by host cells, or does it require the vesicle for delivery? 2.If SsrA is acting directly on host cells and is not required by the bacteria to maintain colonization, the wild type strain should be able to rescue the ssrA mutant, i.e. if the squid are infected with a 1:1 mixture of the wild type and mutant, the wild type strain should not outcompete the mutant. I am not sure whether competition experiments can be done in this model, since the bacteria are flushed daily, but it would be interesting to see if the mutant bacteria could persist in the squid that is also exposed to the wild type. Reviewer #3: The manuscript 'The non-coding small RNA SsrA is secreted by Vibrio fischeri to modulate critical host responses' by Moriano-Gutierrez et al. studies the influence of the secreted sRNA SsrA of the squid symbiont V. fischeri on its host. The authors discover that, in absence of the ssrA gene, bacterial persistence and luminescence of the squid's light organ is much reduced. Strikingly, this phenomenon is not dependent on SmpB, the natural protein partner of the ssrA gene product, the tmRNA. Therefore, a defect in the bacterial trans-translation ribosome rescue system cannot explain the observed phenotypes. They can detect Vibrio tmRNA outside the bacteria, in host tissue, supporting their model that it is carried along with other stable transcripts into the host via outer membrane vesicles. Finally, the wild-type and the ssrA deletion strains are shown to elicit different host responses (regulated genes in the squid), with an interesting effect on genes related to immune function. The manuscript is well written and presents new insight into the functions of secreted RNAs, and the reported observations are truly novel and exciting. Naturally, one wishes to see more mechanistic detail, for example, a better understanding of how tmRNA may influence host gene expression, whether bacterial tmRNA can be recovered with RIG-I, whether particular regions of the RNA are responsible for the observed phenotypes and so forth. However, we appreciate that this is not an easy experimental system, and would argue that some of those mechanistic question may be addressed in a follow-up paper. Major points: * Since the authors, at this point in time, cannot conclusively prove that SsrA is actively secreted and taken up by the host, strong statement such as "SsrA signaling" and related terms should be softened throughout the paper. True, they do show that tmRNA is present in OMVs and that it can be detected by FISH in host tissue. But this does not prove secretion, it might as well be bacterial cell lysis (which would equally explain the detection of 16S rRNA in host epithelium; Fig. S3). * Are the effects on the host specific to the tmRNA of Vibrio fischeri? The authors should at least attempt to complement the ssrA deletion strain with ssrA genes from evolutionary related or distant bacteria, so see whether this "signaling" is a trait that evolved in this specific symbiosis. * Several of the figures/tables lack appropriate labeling (the labels of Fig 1C are missing the log base and it is not stated what was compared to calculate the fold change; Fig 2 contains several cut-off error bars; Fig 5B is only showing half of the error bars; Figs 2, 3C', 5B, S1A, S1A', S2B, S5C, S6A', S6B should show all data points). * Table 1 gives the number of reads for certain ncRNAs in OMVs and haemolymph. This is uninformative without knowledge of the total number of reads and should be changed to give normalized percentages instead. * Further, some of the data important for the major conclusions seem to be over/misinterpreted. In lines 113-116, the indicated difference shown in figure 2A might be statistically significant, but the decrease shown is marginal at best. Thus, the statement on line 119-120 is premature at this point. Line 174-175 and the abstract state that the ssrA knockout mutant reduces luminescence by 90% but Figure 2E does not support this statement. Similarly, all data shown in Fig 5B show strong variance but is still used for important conclusions such as that CIKS expression is only affected by tmRNA-deficient OMVs, whereas wt OMVs had no effect. Given the data presented, this seems like an over interpretation and the authors should avoid this conclusion and rephrase line 358-366 and move it to the discussion. This also means that the model shown in Fig 5C, much of which is based on Fig 5B, should be re-evaluated. Finally, the numbers of replicates for the data shown in Fig 5B are missing. * The authors exclusively focus on the function of tmRNA as a secreted molecule, given that the smpB knockout background shows similar behavior as the wt. Yet, it is important to at least discuss the possibility of tmRNA having additional functions in the bacteria that might explain the observations. Could the host effects stem from a tmRNA function as a regulatory RNA in the bacteria? * The Conclusions section should be changed into a proper discussion, where the authors should more critically reflect upon the strengths and weaknesses of their present model and discuss it in more detail with the available literature. On the latter, see recent work from the Cossart laboratory in Paris discovering putative RNA export and delivery of bacterial transcripts to RIG-I (PMID: 31761719, PMID: 31951583). Minor points: * When referring to the RNA, please use tmRNA; ssrA is the gene name. * Supplementary file 1: For easy data access, VF_XXXX locus tags might be more useful to the community than the shown GeneIDs, which do not seem to be part of the indicated annotations * Lines 36-38: reference 16 does not seem relevant as it focuses on DNA and plasmids found in OMVs, it does not concern the host response. * Lines 95-97: The authors refer to tRNAs and ncRNAs as ORFs. Please correct this. Additionally, it is odd that not a single mRNA was detected in these OMVs. * Lines 108-110: reference 46 is only refers to OMVs and spread in mice. Please adjust statement or reference included in the indicated lines ("…as reported in other animals."). * Fig S2D: Why does the complementation of ssrA lead to such an increase in smpB mRNA levels? * Lines 124-126: please indicate the samples per group. * Line 113 may refer to Fig S1C. * Line 145 should refer to Fig 1D (twice). * Line 148: the mentioned data not shown data seem very interesting and could be included in the manuscript * Line 150 should refer to Fig 1E. * Line 219: "their induction suggested that the host treats the ΔssrA colonization as an undesired infection" This statement should be re-phrased, there is currently no proof for it. * Line 306: "the yolk sac had significantly decreased not only in area, but also to a significantly greater extent". Please re-phrase for clarity. |
| Revision 2 |
|
Dear Dr Ruby, Thank you for submitting your revised Research Article entitled "The non-coding small RNA SsrA is released by Vibrio fischeri and modulates critical host responses" for publication in PLOS Biology. I have now obtained advice from two of the original reviewers and have discussed their comments with the Academic Editor. We're delighted to let you know that we're now editorially satisfied with your manuscript. However before we can formally accept your paper and consider it "in press", we also need to ensure that your article conforms to our guidelines. A member of our team will be in touch shortly with a set of requests. As we can't proceed until these requirements are met, your swift response will help prevent delays to publication. Please also make sure to address the data and other policy-related requests noted at the end of this email. To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following: - a cover letter that should detail your responses to any editorial requests, if applicable - a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable) - a track-changes file indicating any changes that you have made to the manuscript. *Copyediting* Upon acceptance of your article, your final files will be copyedited and typeset into the final PDF. While you will have an opportunity to review these files as proofs, PLOS will only permit corrections to spelling or significant scientific errors. Therefore, please take this final revision time to assess and make any remaining major changes to your manuscript. NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines: https://journals.plos.org/plosbiology/s/supporting-information *Published Peer Review History* Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details: https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/ *Early Version* Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article. *Protocols deposition* To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods Please do not hesitate to contact me should you have any questions. Sincerely, Roli Roberts Roland G Roberts, PhD, Senior Editor, PLOS Biology ------------------------------------------------------------------------ DATA POLICY REQUIREMENTS: You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797 Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms: 1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore). 2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication. Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it: Figs 1BC, 2ABCDE, 3A’BC’D, 4BCD’, 5B S1AB, S2ABCDE, S6BCDE, S7A’B. NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values). Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend. Please ensure that your Data Statement in the submission system accurately describes where your data can be found. ------------------------------------------------------------------------ BLOT AND GEL REPORTING REQUIREMENTS: For manuscripts submitted on or after 1st July 2019, we require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements ------------------------------------------------------------------------ REVIEWERS' COMMENTS: Reviewer #1: The authors have addressed all the reviewer's comments in detail. This is a fascinating manuscript that, in my view, should be accepted for publication. Reviewer #2: [identifies herself as Shelley M. Payne] The revised version of the manuscript has addressed my comments and concerns. |
| Revision 3 |
|
Dear Dr Ruby, On behalf of my colleagues and the Academic Editor, Luis Teixeira, I am pleased to inform you that we will be delighted to publish your Research Article in PLOS Biology. The files will now enter our production system. You will receive a copyedited version of the manuscript, along with your figures for a final review. You will be given two business days to review and approve the copyedit. Then, within a week, you will receive a PDF proof of your typeset article. You will have two days to review the PDF and make any final corrections. If there is a chance that you'll be unavailable during the copy editing/proof review period, please provide us with contact details of one of the other authors whom you nominate to handle these stages on your behalf. This will ensure that any requested corrections reach the production department in time for publication. Early Version The version of your manuscript submitted at the copyedit stage will be posted online ahead of the final proof version, unless you have already opted out of the process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. PRESS We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf. We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/. Thank you again for submitting your manuscript to PLOS Biology and for your support of Open Access publishing. Please do not hesitate to contact me if I can provide any assistance during the production process. Kind regards, Alice Musson Publishing Editor, PLOS Biology on behalf of Roland Roberts, Senior Editor PLOS Biology |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .